Related Experiment Video
Updated: May 24, 2026
08:26
Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Published on: February 23, 2024
Personalized medicine: challenge and promise
Judith Salmon Kaur1, Daniel G Petereit
1Mayo Clinic Comprehensive Cancer Center, 200 First Street SW, Rochester, MN 55905, USA. Kaur.judith@mayo.edu
Summary
Personalized medicine offers significant benefits for American Indians and Alaska Natives facing health disparities. Community-based participatory research is key to individualizing cancer care for these diverse populations.
Area of Science:
- Genomics and precision medicine
- Health disparities research
- Community-based participatory research (CBPR)
Background:
- American Indians and Alaska Natives experience significant health disparities.
- Personalized medicine holds promise for addressing these disparities.
- Diverse population participation is crucial for advancing individualized care.
Purpose of the Study:
- To review the potential of personalized medicine for American Indian and Alaska Native populations.
- To explore the challenges and opportunities in individualizing cancer care for these groups.
- To highlight the role of community-based participatory research in this endeavor.
Main Methods:
- Literature review on personalized medicine and health disparities.
- Analysis of community-based participatory research principles.
- Case studies or examples of CBPR in indigenous health (if applicable, otherwise state general principles).
Main Results:
- Personalized medicine can tailor treatments to individual genetic profiles, potentially improving outcomes.
- Overcoming health disparities requires culturally sensitive approaches and community engagement.
- CBPR frameworks facilitate trust, relevance, and sustainability in research.
Conclusions:
- Individualized cancer care holds promise for reducing health disparities in American Indians and Alaska Natives.
- Successful implementation necessitates active community participation and acceptance.
- Community-based participatory research is an essential framework for equitable advancements in personalized medicine.
More Related Videos
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...